Gregory Hemenway, Eric A. Ross, Candice Schwebel, Lu Chen, Efrat Dotan, Fern Anari, Pooja Ghatalia, Andre Rashad Kydd, Matthew R. Zibelman, Elizabeth R. Plimack, Daniel M. Geynisman. "A phase 2 study of gemcitabine plus carboplatin as second-line therapy after prior enfortumab vedotin and pembrolizumab in patients with locally advanced or metastatic urothelial carcinoma.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.tps901